Drug Shortage Report for APO-ALENDRONATE/VITAMIN D3

Last updated on 2019-01-03 History
Report ID 67708
Drug Identification Number 02454475
Brand name APO-ALENDRONATE/VITAMIN D3
Common or Proper name ALENDRONATE/VITAMIN D3 70MG/5600UNIT
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID VITAMIN D3
Strength(s) 70MG 5600UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 4 BLS
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-26
Estimated end date 2019-01-04
Actual end date 2019-01-02
Shortage status Resolved
Updated date 2019-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-01-03 French Compare
v5 2019-01-03 English Compare
v4 2018-12-27 French Compare
v3 2018-12-27 English Compare
v2 2018-11-27 French Compare
v1 2018-11-27 English Compare

Showing 1 to 6 of 6